Attached files
| file | filename |
|---|---|
| EX-23.2 - EX-23.2 - Zyla Life Sciences | eglt-20151231ex23291eb23.htm |
| EX-31.1 - EX-31.1 - Zyla Life Sciences | eglt-20151231ex311e6e960.htm |
| EX-31.2 - EX-31.2 - Zyla Life Sciences | eglt-20151231ex3122eb203.htm |
| EX-32.1 - EX-32.1 - Zyla Life Sciences | eglt-20151231ex3216962bd.htm |
| EX-10.24 - EX-10.24 - Zyla Life Sciences | eglt-20151231ex1024f5029.htm |
| EX-10.16 - EX-10.16 - Zyla Life Sciences | eglt-20151231ex101649259.htm |
| EX-21.1 - EX-21.1 - Zyla Life Sciences | eglt-20151231ex21151cf63.htm |
| EX-32.2 - EX-32.2 - Zyla Life Sciences | eglt-20151231ex322e11149.htm |
| 10-K - 10-K - Zyla Life Sciences | eglt-20151231x10k.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 11, 2016, with respect to the consolidated financial statements included in the Annual Report of Egalet Corporation on Form 10-K for the year ended December 31, 2014. We consent to the incorporation by reference of said report in the Registration Statement of Egalet Corporation on Forms S-8 (File No. 333-194946 and File No 333-204987) and Forms S-3 (File No. 333-202807 and File No 333-209367).
|
/s/ GRANT THORNTON LLP |
|
|
Philadelphia, PA |
|
|
March 11, 2016 |